A tetra-primer amplification refractory mutation system polymerase chain reaction for the evaluation of rs12979860 IL28B genotype

Journal of Viral Hepatitis

Volumn 18, Issue 9, 2011, Pages 628-630

  Galmozzi, E ^a   Menico, B Del ^a   Rametta, R ^a   Dongiovanni, P ^a   Fracanzani, A L ^a   Benedan, L ^a   Borroni, V ^a   Maggioni, P ^a   Fargion, S ^a   Valenti, L ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

chronic hepatitis C; genetics; IL28; interferon lambda; single nucleotide polymorphism; treatment response

Indexed keywords

DNA; INTERLEUKIN 28B; PEGINTERFERON; RIBAVIRIN;

ADULT; ARTICLE; DNA DETERMINATION; FEMALE; GENE AMPLIFICATION; GENE MUTATION; GENETIC ASSOCIATION; GENOTYPE; HEPATITIS C; HUMAN; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; TETRA PRIMER AMPLIFICATION REFRACTORY MUTATION SYSTEM POLYMERASE CHAIN REACTION; TREATMENT RESPONSE;

ADULT; AGED; ALLELES; ANTIVIRAL AGENTS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENETIC TESTING; GENOTYPE; HEPACIVIRUS; HEPATITIS C, CHRONIC; HUMANS; INTERLEUKINS; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE NUCLEOTIDE; RIBAVIRIN; TREATMENT OUTCOME;

EID: 79952237775     PISSN: 13520504     EISSN: 13652893     Source Type: Journal    
DOI: 10.1111/j.1365-2893.2010.01349.x     Document Type: Article

References (7)

1. Ge D, Fellay J, Thompson AJ, et al. Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance. Nature 2009; 461 (7262): 399-401.
2. Rauch A, Kutalik Z, Descombes P, et al. Genetic variation in IL28B is associated with chronic hepatitis C and treatment failure: a genome-wide association study. Gastroenterology 2010; 138 (4): 1338-1345. 45 e1-7.
3. Dellgren C, Gad HH, Hamming OJ, Melchjorsen J, Hartmann R,. Human interferon-lambda3 is a potent member of the type III interferon family. Genes Immun 2009; 10 (2): 125-131.
4. Thomas DL, Thio CL, Martin MP, et al. Genetic variation in IL28B and spontaneous clearance of hepatitis C virus. Nature 2009; 461 (7265): 798-801.
5. Thompson AJ, Muir AJ, Sulkowski MS, et al. IL28B Polymorphism Improves Viral Kinetics and Is the Strongest Pre-treatment Predictor of SVR in HCV-1 Patients. Gastroenterology 2010, in press.
6. Newton CR, Graham A, Heptinstall LE, et al. Analysis of any point mutation in DNA. The amplification refractory mutation system (ARMS). Nucleic Acids Res 1989; 17 (7): 2503-2516. (Pubitemid 19103235)
7. Ye S, Dhillon S, Ke X, Collins AR, Day IN,. An efficient procedure for genotyping single nucleotide polymorphisms. Nucleic Acids Res 2001; 29 (17): E88-8.